PTPA and cancer: This resulted in activation of CDK1 and G2/M accumulation in many preclinical cancer models.302,303 Inhibition of PP2A with LB-100 has been reported to synergize with PD-1 to enhance the reactivity of microstatellite instability colon cancer to immunotherapy.304